Effects of vatinoxan on gastrointestinal motility, sedation, and antinociception during and after long-lasting detomidine infusion in horses.
Authors: Obrochta, Tapio, Raekallio, Gracia Calvo, Pöyhönen, Hagman, Jantunen, Karikoski
Journal: Equine veterinary journal
Summary
# Editorial Summary Alpha-2 agonists such as detomidine are standard sedatives in equine practice, but their peripheral effects—particularly gastrointestinal atony and reduced motility—present clinical challenges during prolonged infusions. This randomised, blinded cross-over study investigated whether vatinoxan, a peripheral alpha-2 antagonist, could mitigate these unwanted effects whilst maintaining adequate sedation and analgesia. Eight horses received two 4-hour infusions (detomidine alone versus detomidine combined with vatinoxan), with gastrointestinal function assessed via borborygmi scoring, marker ball clearance, and faecal output monitored for 72 hours post-infusion. Addition of vatinoxan produced significantly higher borborygmi scores during and immediately after infusion, with horses passing substantially more faeces in the first 8 hours (6.25 kg versus 2.85 kg; p=0.007). Paradoxically, plastic markers were expelled faster with detomidine alone (AUC 3928 versus 2460; p=0.02), suggesting differential effects on different aspects of motility. Sedation remained adequate in both groups, though the combination treatment produced slightly lower sedation scores at the 60-minute mark (median 7 versus 7.5; p=0.04), with no meaningful differences in pain threshold between treatments. For practitioners managing horses requiring extended sedation—whether for standing procedures, orthopaedic work, or travel—vatinoxan may substantially reduce gastrointestinal stasis and associated colic risk, though the reduced sedation at infusion onset warrants careful dose titration and monitoring.
Read the full abstract on PubMed
Practical Takeaways
- •Adding vatinoxan to detomidine infusions may help mitigate the gastrointestinal motility suppression associated with alpha-2 agonist sedation in horses, supporting better gut function during longer procedures
- •While vatinoxan improves GI sounds and faecal output, clinicians should monitor whether the slightly reduced sedation at 1 hour impacts clinical effectiveness for longer procedures
- •Consider vatinoxan as an adjunct when prolonged detomidine sedation is required in horses at risk for post-operative ileus or GI complications
Key Findings
- •Vatinoxan combined with detomidine significantly increased borborygmi scores during infusion and for 1 hour post-infusion (p < 0.05)
- •Horses receiving detomidine + vatinoxan passed significantly more faeces in the first 8 hours post-infusion (6.25 kg vs 2.85 kg, p = 0.007)
- •Plastic marker expulsion was paradoxically faster with detomidine alone (AUC 3928 ± 1620 vs 2460 ± 1199, p = 0.02)
- •Sedation score was slightly but significantly lower at 60 minutes with detomidine + vatinoxan (7 vs 7.5, p = 0.04), with no difference in antinociception between treatments